日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

The evolution of RET inhibitor resistance in RET-driven lung and thyroid cancers

RET 抑制剂在 RET 驱动的肺癌和甲状腺癌中的耐药性演变

Ezra Y Rosen #, Helen H Won #, Youyun Zheng, Emiliano Cocco, Duygu Selcuklu, Yixiao Gong, Noah D Friedman, Ino de Bruijn, Onur Sumer, Craig M Bielski, Casey Savin, Caitlin Bourque, Christina Falcon, Nikeysha Clarke, Xiaohong Jing, Fanli Meng, Catherine Zimel, Sophie Shifman, Srushti Kittane, Fan Wu,

A case of Evans syndrome secondary to COVID-19

一例由新冠肺炎引起的埃文斯综合征病例

Demir, Nazlim Aktug; Basturk, Abdulkadir; Ural, Onur; Sumer, Sua; Erdogdu, Batuhan; Kiratli, Hatice E; Celik, Jale B; Koplay, Mustafa; Vatansev, Husamettin

3D clusters of somatic mutations in cancer reveal numerous rare mutations as functional targets

癌症体细胞突变的三维簇揭示了许多罕见突变作为功能靶点

Jianjiong Gao, Matthew T Chang, Hannah C Johnsen, Sizhi Paul Gao, Brooke E Sylvester, Selcuk Onur Sumer, Hongxin Zhang, David B Solit, Barry S Taylor, Nikolaus Schultz, Chris Sander1

Perturbation biology nominates upstream-downstream drug combinations in RAF inhibitor resistant melanoma cells

扰动生物学提名 RAF 抑制剂耐药黑色素瘤细胞中的上下游药物组合

Anil Korkut, Weiqing Wang, Emek Demir, Bülent Arman Aksoy, Xiaohong Jing, Evan J Molinelli, Özgün Babur, Debra L Bemis, Selcuk Onur Sumer, David B Solit, Christine A Pratilas, Chris Sander